News
Pharmacy & healthcare news
Industry updates, regulation, and developments that matter to Indian pharmacies.
Tech Mahindra and NVIDIA Collaborate to Advance Drug Safety Using Agentic AI
Tech Mahindra, in collaboration with NVIDIA, has introduced an advanced pharmacovigilance (PV) solution powered by agentic AI technology.
Mar 19, 2025
High Discounts Fuel Counterfeit Drug Surge in West Bengal, Warns AIDCOC
The All India Drug Control Officers Confederation (AIDCOC) has raised serious concerns about the role of high-discount pharmacies in the spread of counterfeit and substandard medicines in West Bengal.
Mar 18, 2025
Rifampicin Drug Used in TB Treatment Expected to Be Commissioned Later This Year
Rifampicin, an essential drug used for treating Tuberculosis (TB) and serious bacterial infections, is expected to be commissioned later this year, with production at an advanced stage of execution, according to official sources.
Mar 17, 2025
Huge Cache of Banned Cough Syrups Seized in Vadodara, Medical Store Owners Arrested
The Vadodara Special Operations Group (SOG), in collaboration with the Food and Drug Control Department, has seized banned cough syrups and capsules worth ₹26.54 lakh and arrested two medical store owners for illegal stocking and sale of codeine-based medicines.
Mar 16, 2025
Sun Pharma and Zydus Pharmaceuticals Voluntarily Recall Drugs in US for Quality Issues
Indian pharmaceutical behemoths Sun Pharma and Zydus Pharmaceuticals are voluntarily recalling certain batches of drugs from the US market based on quality-related manufacturing issues, according to the latest Enforcement Report released by the US Food and Drug Administration (USFDA).
Mar 16, 2025
Dr Reddy’s Recalls Mislabelled Levetiracetam Injection in the US Due to Risk of Adverse Events
Dr Reddy's Laboratories has announced a voluntary recall of a batch of Levetiracetam injection bags in the US market after discovering labelling discrepancies that could lead to patients receiving double the intended dose, posing severe health risks.
Mar 15, 2025
Skin Cream, Nasal Spray and Blindness AIIMS Doctors Warn Steroid Misuse Could Cause Vision Loss
Doctors at AIIMS have raised an alarm over the misuse of steroid-based medicines such as inhalers, nasal sprays, and skin creams, cautioning that prolonged or unmonitored use could silently lead to glaucoma and irreversible vision loss.
Mar 15, 2025
Surge in Paediatric Pneumonia Cases Highlights Growing Antibiotic Resistance in Bengaluru
Bengaluru is witnessing a significant increase in pneumonia cases among children, raising concerns among healthcare professionals about escalating antibiotic resistance.
Mar 15, 2025
MIT Engineers Convert Skin Cells to Neurons for Future Cell Therapy
MIT researchers have developed an advanced method to efficiently convert skin cells directly into motor neurons, bypassing the intermediate stem cell stage.
Mar 13, 2025
EU Plans to Reduce Dependence on Asia for Antibiotics and Essential Medicines
The European Commission has unveiled plans to reduce the EU's reliance on Asia, particularly China and India, for essential medicines, including antibiotics.
Mar 12, 2025
Zydus Gets FDA Final Approval for Methenamine Hippurate Tablets to Treat UTI
Zydus Lifesciences has obtained final approval from the US Food and Drug Administration (FDA) to manufacture and sell Methenamine Hippurate tablets, a generic drug for urinary tract infection (UTI) treatment.
Mar 12, 2025
Mineralys' Drug for Persistent Hypertension Succeeds in Two Trials
Mineralys Therapeutics reported that its flagship drug, lorundrostat, has been successful in reducing blood pressure in patients with uncontrolled hypertension in both late-stage and mid-stage clinical trials.
Mar 11, 2025
Pregabalin Capsules Worth ₹1.25 Lakh Impounded from Chemist
Joint inspection by the local police and the Drugs Control Office resulted in the impounding of banned pregabalin capsules valued at ₹1.25 lakh from a chemist shop at Chhehharta, Amritsar.
Mar 11, 2025
Steadfast Nutrition Launches Ayurvedic Shilajit Formula for Energy and Well-being
Steadfast Nutrition, a prominent sports and wellness nutrition company, has launched Shilajt, an exclusive combination of Shilajit, Swarna Vark (24K gold), Ashwagandha, Kali Musli, and Gokhru, designed to enhance energy, vitality, and general well-being.
Mar 11, 2025
Zydus Lifesciences to Buy Amplitude Surgical for €257 Million
Zydus Lifesciences Ltd. has signed exclusive talks to buy a majority stake in France's Amplitude Surgical for €256.8 million.
Mar 11, 2025
Ayushman Bharat Medicine Scam Exposed at PGIMER, Multi-State Investigation Underway
A huge scam in the misuse of medicines under the Ayushman Bharat cashless health scheme has been exposed at the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh. The multi-state scam, in which such medicines were fraudulently purchased and unlawfully sold to others, is being investigated by law enforcement agencies.
Mar 10, 2025
Empagliflozin Price Falls to ₹9 per Tablet in India Post-Patent Expiry
In a huge relief to more than 10 crore diabetes patients in India, the cost of Empagliflozin, an essential anti-diabetic medicine, will decrease from ₹60 to as little as ₹9 per tablet.
Mar 10, 2025
Sun Pharma to Expand Oncology and Dermatology Portfolio with $355 Million Checkpoint Therapeutics Acquisition
Sun Pharmaceutical Industries Ltd. has disclosed a $355 million takeover of US company Checkpoint Therapeutics, a immunotherapy and targeted oncology therapy specialist. The acquisition is designed to add further strength to Sun Pharma's onco-derm (global oncology and dermatology) portfolio, led by the addition of UNLOXCYT (cosibelimab-ipdl), a US FDA-approved treatment for metastatic cutaneous squamous cell carcinoma (cSCC). The deal is scheduled to close during the second quarter of 2025, increasing Sun Pharma's stronghold in the emerging immunotherapy space.
Mar 10, 2025
UK MHRA Approves Bavarian Nordic's Application for Chikungunya Vaccine for People Aged 12 Years and Above
The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has confirmed the marketing authorization application (MAA) for Bavarian Nordic's chikungunya vaccine, CHIKV VLP, which is a single-dose vaccine. The vaccine is to be used for active immunization against chikungunya virus infections in people aged 12 years and above. The application was submitted under the procedure of international recognition, following a favorable opinion by the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP). The vaccine, previously approved in the United States and European Union as Vimkunya, is now waiting for possible UK approval in the first half of 2025.
Mar 10, 2025
West Bengal Drug Authority Directs Withdrawal of False Hypertension Medicine
The Directorate of Drugs Control (DDC), West Bengal has ordered an immediate recall of a particular batch of Telma-AM, a very popular anti-hypertension drug.
Mar 10, 2025
CDSCO Declares 145 Drug Samples as Not of Standard Quality in February
The Central Drugs Standard Control Organisation (CDSCO) has recognized 145 drug samples as Not of Standard Quality (NSQ) after thorough testing throughout India in February 2025. The increase in NSQ cases is due to more reporting by State drug control offices, enhancing quality monitoring.
Mar 1, 2025
Eli Lilly Launches Ad Campaign Warning Against Unapproved Weight-Loss Drug Copies
Eli Lilly, a major drug company, has introduced a new ad campaign cautioning customers against unapproved weight-loss medications. The step has been interpreted as a measure to combat competition from compounded versions of its weight-reduction medication, Zepbound, promoted by telehealth businesses and compounding pharmacies.
Mar 1, 2025
Kerala Introduces Free Growth Hormone Therapy Under KARE Scheme to Benefit Children With Rare Diseases
Kerala has introduced free growth hormone therapy under the KARE (Kerala United Against Rare Diseases) scheme, making essential treatment available for children suffering from rare growth disorders. The move, made by Kerala Health Minister Veena George on World Rare Disease Day, is a major achievement in the state's rare disease care.
Mar 1, 2025
Sun Pharma Targets Global Launch of Its Anti-Obesity Drug Within Five Years
Sun Pharmaceutical Industries, India's largest drugmaker in terms of revenue, said it plans to launch an experimental anti-obesity and type 2 diabetes drug in four to five years. The company is joining the expanding weight-loss medicine market, which is expected to hit $150 billion worldwide by the end of the decade.
Mar 1, 2025
Ready to simplify your pharmacy?
Start your free 7-day trial or book a personalised demo today.